Trials / Terminated
TerminatedNCT01444209
Radioactive Iodine Implants for Pan-invasive Pituitary Macroadenomas
Interstitial Radioactive Iodine Implants for the Treatment of Pan-invasive Pituitary Macroadenomas
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- University of Texas Southwestern Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study is a single arm Phase II pilot trial. Patients enrolled on the trial will undergo implantation of high activity iodine-125 seeds into their pituitary adenoma. The tumor response to treatment will be monitored as well as change in visual fields, associated adverse effects, progression free survival and patient reported outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Iodine Implants | Interstitial Radioactive Iodine Implants |
Timeline
- Start date
- 2011-09-30
- Primary completion
- 2020-10-20
- Completion
- 2021-01-20
- First posted
- 2011-09-30
- Last updated
- 2021-11-30
- Results posted
- 2021-11-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01444209. Inclusion in this directory is not an endorsement.